| |
|
|
| |
Medical Professionals
For many medical professionals who are looking for alternatives to bone autograft, the Accell family of products is rapidly becoming the clinical solution of choice. The drawbacks of autograft are well documented. The harvesting procedure adds to the overall time and cost of the bone graft procedure, presents the potential for infection at the bone harvest site and carries the risk of injuring surrounding structures. Furthermore, patients may experience greater pain and discomfort at the harvest site than at the primary operative site, which can lead to reduced patient satisfaction. Finally, each patient has a limited supply of autograft bone, as only a limited amount of bone is available for harvest without causing adverse medical consequences.
Our Accell technology provides the basis for a range of products derived from demineralized bone matrix (DBM), which in combination with DBM particles contribute to the potential osteoinductive effect of the product. With our Accell products, we believe we can offer orthopedic surgeons an attractive alternative where price is a consideration. Our Accell products can be used safely and effectively to promote bone growth in the vast majority of patients and at a much reduced expense for hospitals, patients and third party payers. |
|
|
|
